Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04404283
Brief Title: Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

First Submitted : May 21, 2020
First Submitted that Met QC Criteria : May 21, 2020
First Posted : May 27, 2020

Last Update Submitted that Met QC Criteria : February 28, 2021
Last Update Posted : March 2, 2021